The FDA approves a new test to look at... - Lung Cancer Support

Lung Cancer Support

3,999 members2,169 posts

The FDA approves a new test to look at mutations in many types of cancers, including lung cancer

MFH_Advocate profile image
4 Replies

Yesterday the FDA approved a test that can detect mutations in 324 genes and two genomic signatures in any type of solid tumor (including lung cancer). The Centers for Medicare & Medicaid Services (CMS) also proposed coverage of this test. This one test could allow doctors to better understand the profile of a patient's tumor and prescribe personalized targeted therapies. And, the cost of the test could be covered by Medicare or Medicaid for eligible patients. cms.gov/Newsroom/MediaRelea...

Written by
MFH_Advocate profile image
MFH_Advocate
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Denzie profile image
DenzieModeratorVolunteer

This is awesome. In the cases where it doesn’t find a useful, Targetable mutation it may tell them what won’t work. Besides saving money not giving a treatment that won’t work it will save the patient unnecessary side effects. Something advocates have pushed strongly for.

scifiknitter profile image
scifiknitterBlogger

Great news - this will extend lives!

FtB_Peggy profile image
FtB_Peggy

Thanks Mary, very exciting and hopeful.

JeanE41 profile image
JeanE41

Another step in the right direction.

You may also like...

IMRT appeal denied for a SECOND time - case closed now

said it will be detrimental to him given the tumor is pressing into his heart nor will my dad agree...

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

fda.gov/drugs/resources-information-approved-drugs/fda-approves-atezolizumab-first-line-treatment-me

First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)

the full FDA press release:...

Foundation One genetic testing

assistance yesterday as self-patient pay. Less than 24 hours later he got approved for 100 percent...

Farewell to our dear friend Anita

of many. She travelled across the country as a patient advocate, speaking to groups of...